Home › Uveal Melanoma › Illinois › Chicago
Uveal Melanoma clinical trials in Chicago, IL
3 studies for Uveal Melanoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RecruitingPhase 1/2
- University of Chicago Medical Center, Chicago
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RecruitingPhase 2/3
- Northwestern Memorial Hospital, Chicago
- University of Chicago Medical Center, Chicago
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
RecruitingPhase 2
- University of Chicago Medical Center, Chicago
Uveal Melanoma trials in other cities
- Philadelphia, PA7 studies
- Los Angeles, CA6 studies
- Nashville, TN6 studies
- New York City, NY5 studies
- Boston, MA5 studies
- Columbus, OH5 studies
- Houston, TX5 studies
- Denver, CO5 studies
- Scottsdale, AZ5 studies
- Miami, FL4 studies
- Tampa, FL4 studies
- Mountain View, CA4 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.